The eligibility of Lifeward’s ReWalk Personal Exoskeleton under the Nairobi Protocol treatment from Israel
No revocation or modification of this ruling appears in the Customs Bulletin issues read here (Nov 6, 2024 through Nov 18, 2026), where CBP publishes most such actions. That is not confirmation that the ruling is still in effect. Confirm its status with CBP before relying on it (ruling on CBP CROSS).
Ruling text
In your letter dated November 3, 2025, you requested a tariff classification ruling on behalf of your client, Lifeward Inc. The product under consideration is Lifeward’s ReWalk Personal Exoskeleton, which is a wearable robotic exoskeleton (bionic walking assistance system) that provides powered hip and knee motion to enable individuals with a spinal cord injury to stand upright, walk, turn, and climb and descend stairs.
The system provides user-initiated mobility through the integration of a wearable brace support, a computer-based control system, motion sensors, a wrist-mounted remote, and forearm crutches. It allows independent, controlled walking while mimicking the natural gait patterns of the legs. You state the design, form, and use of the exoskeleton make it easily distinguishable from articles useful to non-handicapped persons.
The device is only useful to those who have lost the use of their legs and the ability to walk, and has no characteristics that would create a probability of use by members of the general public who are not suffering from a severe spinal cord injury. The exoskeletons are manufactured and imported by Lifeward, a medical device company, that specializes in technologies to enable mobility and wellness in rehabilitation for individuals with physical and neurological conditions.
The ReWalk Personal Exoskeleton is not sold in retail outlets for the general public. Rather, these articles are sold directly to handicapped individuals who require them. You claim that at the time of entry, all parts of the exoskeleton are clearly and unequivocally designed for use by individuals unable to walk and are suitable for no other use. You confirm that the ReWalk Personal Exoskeleton is not an article for the treatment of an acute or transient disability.
It is designed for the use of paraplegics who have lost complete use of their legs – a permanent handicap. It will last a person’s entire life and is by no means temporary. In your submission you requested consideration of a classification under 9817.00.96, Harmonized Tariff Schedule of the United States (HTSUS), which applies to articles and parts and accessories of articles specifically designed or adapted for the use or benefit of the permanently or chronically physically or mentally handicapped.
Subheading 9817.00.96, HTSUS, covers: “Articles specially designed or adapted for the use or benefit of the blind or other physically or mentally handicapped persons; parts and accessories (except parts and accessories of braces and artificial limb prosthetics) that are specially designed or adapted for use in the foregoing articles . . .
Other.” The term “blind or other physically or mentally handicapped persons” includes “any person suffering from a permanent or chronic physical or mental impairment which substantially limits one or more major life activities, such as caring for one’s self, performing manual tasks, walking, seeing, hearing, speaking, breathing, learning, or working.” U.S. Note 4(a), Subchapter XVII, Chapter 98, HTSUS.
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (N355678).